Find out more about Orbit Health’s AI solution for Parkinson’s disease treatment.
€1.5m investment for AI solution helping “personalise” Parkinson’s treatment
Author: Johanna Stiefler JohnsonPublished: 11 February 2021
Prep: Cook: Serves:
Germany-based Orbit Health was recently awarded a €1.5m investment for its pioneering AI solution that could help clinicians “personalise treatments” for people living with Parkinson’s disease
Orbit Health, a health tech company based in Munich, Germany, has been awarded an investment to bolster its project ‘Neptune’, an artificial intelligence (AI) solution aiming to improve the personalisation of Parkinson’s disease treatments.
The €1.5m investment was awarded by EIT Health, a healthcare innovation network backed by the European Union, as part of its 2020 Wild Card programme. The annual event calls for groundbreaking solutions to unmet healthcare needs.
This year, two winning teams were selected – Orbit Health and Spain-based women’s health company MiMARK. As well as financial support, the teams will receive expert mentoring and coaching as part of the two-year investment.
Patty Lee, CEO and co-founder of Orbit Health, said: “Parkinson’s is a complicated disease, and every patient reacts to treatment differently. Our solution equips clinicians with reliable, continuous, and objective symptom insights that are easy to access to effectively personalise treatments for each patient.
“Our ultimate goal is to improve the quality of life for both the patients and their families and address the cost-efficiency of the healthcare system. In the future, our solution could even help guide treatment options for each individual patient.”
Orbit Health’s AI solution uses a smart watch to capture and analyse data on how people with Parkinson’s disease respond to treatment. This enables clinicians to track individual patients’ symptoms, adjust their care accordingly – and helps improve patients’ quality of life.
“Chronic disease continues to be on the rise, and health systems struggle to manage growing demands and financial sustainability,” said Dr Franz Pfister, co-founder of Orbit Health. “We have to put patients in the centre of healthcare delivery and leverage the advancement in digital health.
“It is Orbit’s long-term vision to enable digital health solutions, integrate them into clinical practice and promote community and home health to play key roles in the prevention, detection and the management of chronic conditions.”
Reflecting on Orbit Health’s participation in the Wild Card programme, Lee added: “Wild Card 2020 was a truly enriching experience that accelerated our understanding of how our solution fits into the market. We look forward to leveraging EIT Health’s support, network and influence to deliver our solution into the hands of clinicians and patients.”
For more information on Parkinson’s assessment tools, please visit Parkinson’s Europe website.
Innovative treatment for late stage Parkinson’s disease could be launched in Europe
Ask the expert: Are online innovations the future of Parkinson’s treatment?
Share this story
10 breakthrough Parkinson’s therapies to watch out for
Coffee to marijuana, the broader breakthrough picture is excitingREAD MORE
Parkinson’s AI trial launched by Chinese tech giant
The study will take place in LondonREAD MORE
Cutting-edge technologies that could treat Parkinson’s
Find out how vibrating socks, a wearable airbag and a swallow sensor couldREAD MORE